AbbVie seeks lift from ‘guided missile’ cancer drug with $10 billion ImmunoGen deal
Post Content
Similar Posts
UK Chancellor outlines fiscal strategy amid economic challenges
Post Content Post Views: 107
Horizons High Interest Savings ETF declares CAD 0.215 dividend
Post Content Post Views: 91
Bank of India introduces competitive home loan rates
Post Content Post Views: 84
Nvidia shares inch lower with upcoming quarterly earnings, China outlook in focus
Post Content Post Views: 93
Australia appoints BoE’s Andrew Hauser as new RBA deputy head
Post Content Post Views: 95
Timbercreek Financial Corp. declares $0.0575 dividend
Post Content Post Views: 95